PMC:7445716 / 44063-44554 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T227","span":{"begin":34,"end":39},"obj":"Body_part"},{"id":"T228","span":{"begin":60,"end":72},"obj":"Body_part"},{"id":"T229","span":{"begin":220,"end":223},"obj":"Body_part"},{"id":"T230","span":{"begin":257,"end":264},"obj":"Body_part"},{"id":"T231","span":{"begin":284,"end":288},"obj":"Body_part"},{"id":"T232","span":{"begin":425,"end":432},"obj":"Body_part"}],"attributes":[{"id":"A227","pred":"fma_id","subj":"T227","obj":"http://purl.org/sig/ont/fma/fma9576"},{"id":"A228","pred":"fma_id","subj":"T228","obj":"http://purl.org/sig/ont/fma/fma82816"},{"id":"A229","pred":"fma_id","subj":"T229","obj":"http://purl.org/sig/ont/fma/fma278683"},{"id":"A230","pred":"fma_id","subj":"T230","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A231","pred":"fma_id","subj":"T231","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A232","pred":"fma_id","subj":"T232","obj":"http://purl.org/sig/ont/fma/fma82839"}],"text":"Camdessanche et al. [11] RT-PCR + chest CT NA Negative anti-gangliosides antibodies; negative screening for Campylobacter jejuni, Mycoplasma pneumoniae, Salmonella enterica, CMV, EBV, HSV1-2, VZV, Influenza virus A \u0026 B, HIV, and hepatitis E Increased total protein (1.66 g/L), normal cell count Demyelinating\nAIDP NA IVIG 400 mg/kg (5 days) + mechanical invasive ventilation Oxygen therapy, paracetamol, low molecular weight heparin, lopinavir/ritonavir 400/100 mg twice a day for 10 days NA"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T121","span":{"begin":34,"end":39},"obj":"Body_part"}],"attributes":[{"id":"A121","pred":"uberon_id","subj":"T121","obj":"http://purl.obolibrary.org/obo/UBERON_0001443"}],"text":"Camdessanche et al. [11] RT-PCR + chest CT NA Negative anti-gangliosides antibodies; negative screening for Campylobacter jejuni, Mycoplasma pneumoniae, Salmonella enterica, CMV, EBV, HSV1-2, VZV, Influenza virus A \u0026 B, HIV, and hepatitis E Increased total protein (1.66 g/L), normal cell count Demyelinating\nAIDP NA IVIG 400 mg/kg (5 days) + mechanical invasive ventilation Oxygen therapy, paracetamol, low molecular weight heparin, lopinavir/ritonavir 400/100 mg twice a day for 10 days NA"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T468","span":{"begin":130,"end":151},"obj":"Disease"},{"id":"T469","span":{"begin":197,"end":206},"obj":"Disease"},{"id":"T470","span":{"begin":229,"end":240},"obj":"Disease"},{"id":"T471","span":{"begin":229,"end":238},"obj":"Disease"},{"id":"T472","span":{"begin":309,"end":313},"obj":"Disease"}],"attributes":[{"id":"A468","pred":"mondo_id","subj":"T468","obj":"http://purl.obolibrary.org/obo/MONDO_0005867"},{"id":"A469","pred":"mondo_id","subj":"T469","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A470","pred":"mondo_id","subj":"T470","obj":"http://purl.obolibrary.org/obo/MONDO_0005788"},{"id":"A471","pred":"mondo_id","subj":"T471","obj":"http://purl.obolibrary.org/obo/MONDO_0002251"},{"id":"A472","pred":"mondo_id","subj":"T472","obj":"http://purl.obolibrary.org/obo/MONDO_0020347"}],"text":"Camdessanche et al. [11] RT-PCR + chest CT NA Negative anti-gangliosides antibodies; negative screening for Campylobacter jejuni, Mycoplasma pneumoniae, Salmonella enterica, CMV, EBV, HSV1-2, VZV, Influenza virus A \u0026 B, HIV, and hepatitis E Increased total protein (1.66 g/L), normal cell count Demyelinating\nAIDP NA IVIG 400 mg/kg (5 days) + mechanical invasive ventilation Oxygen therapy, paracetamol, low molecular weight heparin, lopinavir/ritonavir 400/100 mg twice a day for 10 days NA"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T275","span":{"begin":21,"end":23},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T276","span":{"begin":34,"end":39},"obj":"http://www.ebi.ac.uk/efo/EFO_0000965"},{"id":"T277","span":{"begin":207,"end":212},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T278","span":{"begin":213,"end":214},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T279","span":{"begin":217,"end":218},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T280","span":{"begin":284,"end":288},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T281","span":{"begin":471,"end":472},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Camdessanche et al. [11] RT-PCR + chest CT NA Negative anti-gangliosides antibodies; negative screening for Campylobacter jejuni, Mycoplasma pneumoniae, Salmonella enterica, CMV, EBV, HSV1-2, VZV, Influenza virus A \u0026 B, HIV, and hepatitis E Increased total protein (1.66 g/L), normal cell count Demyelinating\nAIDP NA IVIG 400 mg/kg (5 days) + mechanical invasive ventilation Oxygen therapy, paracetamol, low molecular weight heparin, lopinavir/ritonavir 400/100 mg twice a day for 10 days NA"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T243","span":{"begin":43,"end":45},"obj":"Chemical"},{"id":"T244","span":{"begin":60,"end":72},"obj":"Chemical"},{"id":"T245","span":{"begin":257,"end":264},"obj":"Chemical"},{"id":"T246","span":{"begin":314,"end":316},"obj":"Chemical"},{"id":"T247","span":{"begin":375,"end":381},"obj":"Chemical"},{"id":"T248","span":{"begin":391,"end":402},"obj":"Chemical"},{"id":"T249","span":{"begin":425,"end":432},"obj":"Chemical"},{"id":"T250","span":{"begin":434,"end":453},"obj":"Chemical"},{"id":"T251","span":{"begin":434,"end":443},"obj":"Chemical"},{"id":"T252","span":{"begin":444,"end":453},"obj":"Chemical"},{"id":"T253","span":{"begin":489,"end":491},"obj":"Chemical"}],"attributes":[{"id":"A243","pred":"chebi_id","subj":"T243","obj":"http://purl.obolibrary.org/obo/CHEBI_33696"},{"id":"A244","pred":"chebi_id","subj":"T244","obj":"http://purl.obolibrary.org/obo/CHEBI_28892"},{"id":"A245","pred":"chebi_id","subj":"T245","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A246","pred":"chebi_id","subj":"T246","obj":"http://purl.obolibrary.org/obo/CHEBI_33696"},{"id":"A247","pred":"chebi_id","subj":"T247","obj":"http://purl.obolibrary.org/obo/CHEBI_15379"},{"id":"A248","pred":"chebi_id","subj":"T248","obj":"http://purl.obolibrary.org/obo/CHEBI_46195"},{"id":"A249","pred":"chebi_id","subj":"T249","obj":"http://purl.obolibrary.org/obo/CHEBI_28304"},{"id":"A250","pred":"chebi_id","subj":"T250","obj":"http://purl.obolibrary.org/obo/CHEBI_145924"},{"id":"A251","pred":"chebi_id","subj":"T251","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A252","pred":"chebi_id","subj":"T252","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"},{"id":"A253","pred":"chebi_id","subj":"T253","obj":"http://purl.obolibrary.org/obo/CHEBI_33696"}],"text":"Camdessanche et al. [11] RT-PCR + chest CT NA Negative anti-gangliosides antibodies; negative screening for Campylobacter jejuni, Mycoplasma pneumoniae, Salmonella enterica, CMV, EBV, HSV1-2, VZV, Influenza virus A \u0026 B, HIV, and hepatitis E Increased total protein (1.66 g/L), normal cell count Demyelinating\nAIDP NA IVIG 400 mg/kg (5 days) + mechanical invasive ventilation Oxygen therapy, paracetamol, low molecular weight heparin, lopinavir/ritonavir 400/100 mg twice a day for 10 days NA"}

{"project":"LitCovid-PubTator","denotations":[{"id":"727","span":{"begin":107,"end":127},"obj":"Species"},{"id":"728","span":{"begin":129,"end":150},"obj":"Species"},{"id":"729","span":{"begin":152,"end":171},"obj":"Species"},{"id":"730","span":{"begin":183,"end":187},"obj":"Species"},{"id":"731","span":{"begin":196,"end":211},"obj":"Species"},{"id":"811","span":{"begin":178,"end":181},"obj":"Species"},{"id":"826","span":{"begin":403,"end":431},"obj":"Chemical"},{"id":"827","span":{"begin":433,"end":452},"obj":"Chemical"},{"id":"886","span":{"begin":228,"end":239},"obj":"Disease"},{"id":"887","span":{"begin":294,"end":312},"obj":"Disease"}],"attributes":[{"id":"A727","pred":"tao:has_database_id","subj":"727","obj":"Tax:197"},{"id":"A728","pred":"tao:has_database_id","subj":"728","obj":"Tax:2104"},{"id":"A729","pred":"tao:has_database_id","subj":"729","obj":"Tax:28901"},{"id":"A730","pred":"tao:has_database_id","subj":"730","obj":"Tax:10298"},{"id":"A731","pred":"tao:has_database_id","subj":"731","obj":"Tax:11308"},{"id":"A811","pred":"tao:has_database_id","subj":"811","obj":"Tax:10376"},{"id":"A826","pred":"tao:has_database_id","subj":"826","obj":"MESH:D006495"},{"id":"A827","pred":"tao:has_database_id","subj":"827","obj":"MESH:C558899"},{"id":"A886","pred":"tao:has_database_id","subj":"886","obj":"MESH:D016751"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Camdessanche et al. [11] RT-PCR + chest CT NA Negative anti-gangliosides antibodies; negative screening for Campylobacter jejuni, Mycoplasma pneumoniae, Salmonella enterica, CMV, EBV, HSV1-2, VZV, Influenza virus A \u0026 B, HIV, and hepatitis E Increased total protein (1.66 g/L), normal cell count Demyelinating\nAIDP NA IVIG 400 mg/kg (5 days) + mechanical invasive ventilation Oxygen therapy, paracetamol, low molecular weight heparin, lopinavir/ritonavir 400/100 mg twice a day for 10 days NA"}

{"project":"LitCovid-sentences","denotations":[{"id":"T227","span":{"begin":0,"end":308},"obj":"Sentence"},{"id":"T228","span":{"begin":309,"end":491},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Camdessanche et al. [11] RT-PCR + chest CT NA Negative anti-gangliosides antibodies; negative screening for Campylobacter jejuni, Mycoplasma pneumoniae, Salmonella enterica, CMV, EBV, HSV1-2, VZV, Influenza virus A \u0026 B, HIV, and hepatitis E Increased total protein (1.66 g/L), normal cell count Demyelinating\nAIDP NA IVIG 400 mg/kg (5 days) + mechanical invasive ventilation Oxygen therapy, paracetamol, low molecular weight heparin, lopinavir/ritonavir 400/100 mg twice a day for 10 days NA"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T646","span":{"begin":141,"end":151},"obj":"Phenotype"},{"id":"T647","span":{"begin":229,"end":238},"obj":"Phenotype"},{"id":"T648","span":{"begin":295,"end":308},"obj":"Phenotype"}],"attributes":[{"id":"A646","pred":"hp_id","subj":"T646","obj":"http://purl.obolibrary.org/obo/HP_0002090"},{"id":"A647","pred":"hp_id","subj":"T647","obj":"http://purl.obolibrary.org/obo/HP_0012115"},{"id":"A648","pred":"hp_id","subj":"T648","obj":"http://purl.obolibrary.org/obo/HP_0011096"}],"text":"Camdessanche et al. [11] RT-PCR + chest CT NA Negative anti-gangliosides antibodies; negative screening for Campylobacter jejuni, Mycoplasma pneumoniae, Salmonella enterica, CMV, EBV, HSV1-2, VZV, Influenza virus A \u0026 B, HIV, and hepatitis E Increased total protein (1.66 g/L), normal cell count Demyelinating\nAIDP NA IVIG 400 mg/kg (5 days) + mechanical invasive ventilation Oxygen therapy, paracetamol, low molecular weight heparin, lopinavir/ritonavir 400/100 mg twice a day for 10 days NA"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T437","span":{"begin":34,"end":39},"obj":"UBERON:0001443"},{"id":"T438","span":{"begin":60,"end":72},"obj":"CHEBI:16856;CHEBI:16856"},{"id":"T439","span":{"begin":73,"end":83},"obj":"GO:0042571"},{"id":"T440","span":{"begin":108,"end":121},"obj":"NCBITaxon:197"},{"id":"T441","span":{"begin":122,"end":128},"obj":"NCBITaxon:6142"},{"id":"T442","span":{"begin":130,"end":151},"obj":"NCBITaxon:2104"},{"id":"T443","span":{"begin":153,"end":172},"obj":"NCBITaxon:562"},{"id":"T444","span":{"begin":174,"end":177},"obj":"NCBITaxon:10358"},{"id":"T445","span":{"begin":179,"end":182},"obj":"NCBITaxon:10376"},{"id":"T446","span":{"begin":184,"end":188},"obj":"NCBITaxon:10298;PR:Q02887"},{"id":"T447","span":{"begin":197,"end":206},"obj":"NCBITaxon:7719"},{"id":"T448","span":{"begin":207,"end":212},"obj":"NCBITaxon:10239"},{"id":"T449","span":{"begin":391,"end":402},"obj":"CHEBI:46195;CHEBI:46195"},{"id":"T450","span":{"begin":425,"end":432},"obj":"CHEBI:24505;CHEBI:24505"},{"id":"T451","span":{"begin":434,"end":443},"obj":"CHEBI:31781;CHEBI:31781;DG_23"},{"id":"T452","span":{"begin":444,"end":453},"obj":"DG_30"}],"text":"Camdessanche et al. [11] RT-PCR + chest CT NA Negative anti-gangliosides antibodies; negative screening for Campylobacter jejuni, Mycoplasma pneumoniae, Salmonella enterica, CMV, EBV, HSV1-2, VZV, Influenza virus A \u0026 B, HIV, and hepatitis E Increased total protein (1.66 g/L), normal cell count Demyelinating\nAIDP NA IVIG 400 mg/kg (5 days) + mechanical invasive ventilation Oxygen therapy, paracetamol, low molecular weight heparin, lopinavir/ritonavir 400/100 mg twice a day for 10 days NA"}

{"project":"2_test","denotations":[{"id":"32840686-32334841-63205757","span":{"begin":20,"end":22},"obj":"32334841"}],"text":"Camdessanche et al. [11] RT-PCR + chest CT NA Negative anti-gangliosides antibodies; negative screening for Campylobacter jejuni, Mycoplasma pneumoniae, Salmonella enterica, CMV, EBV, HSV1-2, VZV, Influenza virus A \u0026 B, HIV, and hepatitis E Increased total protein (1.66 g/L), normal cell count Demyelinating\nAIDP NA IVIG 400 mg/kg (5 days) + mechanical invasive ventilation Oxygen therapy, paracetamol, low molecular weight heparin, lopinavir/ritonavir 400/100 mg twice a day for 10 days NA"}